Exact Mass: 371.0744788

Exact Mass Matches: 371.0744788

Found 39 metabolites which its exact mass value is equals to given mass value 371.0744788, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Arotinolol

5-(2-((3-(tert-Butylamino)-2-hydroxypropyl)thio)thiazol-4-yl)thiophene-2-carboxamide

C15H21N3O2S3 (371.07958460000003)

C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists Arotinolol is a nonselective α/β-adrenergic receptor blocker and a vasodilating β-blocker[1]. Arotinolol also shows potency for inhibiting the binding of the radioligand 125I-ICYP to 5HT1B-serotonergic receptor sites[2]. Arotinolol is an antihypertensive agent for the treatment of a variety of cardiovascular pathologies as well as non-cardiovascular diseases[1].

N,N-Bis(2-chloroethyl)-N',N'-diphenylphosphoric triamide

N,N-Bis(2-chloroethyl)-N,N-diphenylphosphoric triamide

C16H20Cl2N3OP (371.07209800000004)

Arotinolol

5-(2-{[3-(tert-butylamino)-2-hydroxypropyl]sulphanyl}-1,3-thiazol-4-yl)thiophene-2-carboxamide

C15H21N3O2S3 (371.07958460000003)

PYR-41

Ethyl 4-{4-[(5-nitrofuran-2-yl)methylidene]-3,5-dioxopyrazolidin-1-yl}benzoic acid

C17H13N3O7 (371.07534680000003)

3-{3-[2-hydroxybut-3-en-1-yl]-1,2,4-thiadiazol-5-yl}-5,6-dihydrospiro[indoline-3,2-thiopyran]-2-one

C18H17N3O2S2 (371.0762142)

Asn-Met-OH

(S)-2-(3-(2-amino-2-oxoethoxy)-4-nitrobenzamido)-5-(methylthio)pentanoic acid

C14H17N3O7S (371.0787172)

Met-Asn-OH

(S)-5-amino-2-(3-(2-(methylthio)ethoxy)-4-nitrobenzamido)-5-oxopentanoic acid

C14H17N3O7S (371.0787172)

N,N,N,N-Tetramethyl-S-(1-oxido-2-pyridyl)thiuronium hexafluorophosphate

C10H16F6N3OPS (371.0655848)

2-N-BOC-3-(3-BROMO-PHENYL)-2-METHYLAMINOMETHYL-PROPIONIC ACID

C16H22BrNO4 (371.07321120000006)

Benzyl (S)-3-(Boc-amino)-4-bromobutanoate

C16H22BrNO4 (371.07321120000006)

2-N-BOC-3-(4-BROMO-PHENYL)-2-METHYLAMINOMETHYL-PROPIONIC ACID

C16H22BrNO4 (371.07321120000006)

1-{4-[3,5-DI(TRIFLUOROMETHYL)PHENOXY]PHENYL}-1H-PYRROLE

C18H11F6NO (371.0744788)

METHYL 2-N-BOC-2-AMINOMETHYL-3-(3-BROMO-PHENYL)-PROPIONATE

C16H22BrNO4 (371.07321120000006)

1H-1,3,4-Benzotriazepine,2-(2-thienyl)-5-[4-(trifluoromethyl)phenyl]-(9CI)

C19H12F3N3S (371.0703988)

METHYL 2-N-BOC-2-AMINOMETHYL-3-(4-BROMO-PHENYL)-PROPIONATE

C16H22BrNO4 (371.07321120000006)

1-[(1,3,4-trimethyl-4,5-dihydroimidazol-1-ium-2-yl)oxy]pyrrolidine-2,5-dione,hexafluorophosphate

C10H16F6N3O3P (371.0833428)

O-Succinimidyl-1,3-dimethylpropyleneuronium hexafluorophosphate

C10H16N3O3.PF6 (371.08334279999997)

PYR-41

C17H13N3O7 (371.07534680000003)

8-Hydroxy-pipat

C16H22INO (371.0746072)

2-(3-Pyridinyl)-4-[4-(1-pyrrolidinylsulfonyl)phenyl]thiazole

C18H17N3O2S2 (371.0762142)

N-[6-acetyl-3-(1,3-benzothiazol-2-yl)-5,7-dihydro-4H-thieno[2,3-c]pyridin-2-yl]acetamide

C18H17N3O2S2 (371.0762142)

7-hydroxy-PIPAT

C16H22INO (371.0746072)

N-(4-Acetylphenyl)-5-(5-chloro-2,4-dihydroxyphenyl)-1H-pyrazole-4-carboxamide

C18H14ClN3O4 (371.0672794000001)

4-[5-Amino-3-methyl-4-[oxo-[3-(trifluoromethyl)phenyl]methyl]-2-thiophenyl]butanoic acid

C17H16F3NO3S (371.0802942)

3-(1,3-benzothiazol-2-ylsulfanyl)-N-[(E)-(4-methoxyphenyl)methylideneamino]propanamide

C18H17N3O2S2 (371.0762142)

ethyl 4-{(4E)-4-[(5-nitrofuran-2-yl)methylidene]-3,5-dioxopyrazolidin-1-yl}benzoate

C17H13N3O7 (371.07534680000003)

(2R,3S)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C15H22BrN3O3 (371.0844442)

(2R,3R)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C15H22BrN3O3 (371.0844442)

(2S,3R)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C15H22BrN3O3 (371.0844442)

(2R,3S)-8-bromo-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C15H22BrN3O3 (371.0844442)

(2S,3R)-8-bromo-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C15H22BrN3O3 (371.0844442)

(2S,3S)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C15H22BrN3O3 (371.0844442)

(2R,3R)-8-bromo-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C15H22BrN3O3 (371.0844442)

(2S,3S)-8-bromo-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C15H22BrN3O3 (371.0844442)

AS1949490

C20H18ClNO2S (371.07467180000003)

AS1949490 is a potent, orally active, selective SHIP2 phosphatase inhibitor with IC50 values of 0.34, 0.62, 13, >50, >50, and >50 μM for Mouse SHIP2, Human SHIP2, Human SHIP1, Human PTEN, Human synaptojanin, and Human myotubularin, respectively. AS1949490 increases the phosphorylation of Akt, glucose consumption and glucose uptake. AS1949490 activates intracellular insulin signalling pathways. AS1949490 can be used for research of diabetes[1][2].

Azemiglitazone

C19H17NO5S (371.08273920000005)

Azemiglitazone (MSDC-0602) is an orally active thiazolidinedione (TZD) -like molecule, which binds to PPARγ with low binding and activating affinity. Azemiglitazone inhibits mitochondrial pyruvate carrier (MPC), which inhibits Alzheimer’s disease and diminishes nonalcoholic steatohepatitis (NASH) caused liver injury[4][5].